As it concerns GPx3, its serum levels were higher in individuals with MetS compared to controls, and GPx3 gene polymorphism (rs8177409) was related to cardiovascular risk in a Mexican population [137]. This evidence concerns the gene GPX3 and metabolic syndrome.